Ortho/Quidel Reagents and Consumable BPA.

The Department of Health and Human Services Indian Health Service seeks to establish a Blanket Purchase Agreement for Ortho/Quidel laboratory reagents, consumables, and quality control materials, with proposals due August 31, 2026. The procurement is set aside for Indian Small Business Economic Enterprise (ISBE) under the Buy Indian Act, and offerors must self-certify eligibility as an Indian Economic Enterprise with 51% ownership by a federally recognized tribal entity, maintaining that status at offer submission, contract award, and throughout performance.

Place of performance is Lawton, Oklahoma, supporting blood bank operations at Lawton Indian Hospital. The contractor must supply name-brand Ortho/Quidel products compatible exclusively with Ortho MTS and Ortho Vision Swift diagnostic instruments, compliant with 42 CFR Part 493 clinical laboratory testing standards. The NAICS code is 325413, In-Vitro Diagnostic Substance Manufacturing.

The BPA covers a five-year term: base year 2026–2027 and four option years through 2030–2031, with identical pricing across all periods. The pricing schedule includes 23 line items covering reagents (monoclonal and reverse grouping cards, buffered gel cards, DAT and quality control kits, SELECTOGEN and AFFIRMAGEN reagents, BIOCLONE products, and ORTHO CONFIDENCE SYSTEM controls) and consumables (evaporation caps, 7% BSA solution, dilution trays, bottles, and pipet tips). Specific unit prices are not disclosed in the source materials.

Key performance requirements include a secure online ordering portal with 99% uptime and real-time tracking; accurate packing slips with 98% acceptance quality limit; back-order notifications within three business days; invoices within five business days of shipment; monthly shipments with one-week delivery; temperature and storage compliance; and a dedicated single point of contact with toll-free support (8:00 a.m. to 4:30 p.m. Monday–Friday) and two-hour email response time. Contractor personnel require security clearance compliance per HHSAR 304.1300(b), and the facility is tobacco-free with escort and confidentiality requirements.